Belite Bio (BLTE) Receivables - Other (2020 - 2025)

Belite Bio's Receivables - Other history runs 4 years deep, the most recent figure standing at $700000.0 for Q4 2025.

• In Q4 2025, Receivables - Other rose 21.74% year-over-year to $700000.0; the TTM figure through Dec 2025 stood at $700000.0 (up 21.74% YoY), while the FY2025 annual figure was $700000.0, up 21.74% from the prior year.
• Receivables - Other for Q4 2025 stood at $700000.0, up from $6000.0 in the prior quarter.
• The five-year high for Receivables - Other was $818000.0 in Q4 2023, with the low at $2000.0 in Q4 2022.
• The 4-year median for Receivables - Other is $315500.0 (2024), against an average of $359500.0.
• The sharpest annual moves came in 2023 and 2025: Receivables - Other jumped 40800.0% in 2023, then tumbled 89.29% in 2025.
• Belite Bio's Receivables - Other stood at $2000.0 in 2022, then surged by 40800.0% to $818000.0 in 2023, then dropped by 29.71% to $575000.0 in 2024, then gained by 21.74% to $700000.0 in 2025.
• Business Quant data shows BLTE's Receivables - Other at $700000.0 in Q4 2025, $6000.0 in Q3 2025, and $575000.0 in Q4 2024.